John has spent over 30 years researching and developing various technologies associated with IL-10. His work experience included various leadership roles at Anergen, Introgen Therapeutics, Bacterial BarCodes, Schering-Plough, Merck, Targenics, ARMO BioSciences, ACIR BioSciences, and MedImmune/AstraZeneca. John’s primary focus has been on discovery research at the interface between cancer biology and the adaptive immune response.

• 

  President in DEKA Biosciences

  We can build a Diakine™ for every patient.

• 

  Chief Executive Officer (CEO) in DEKA Biosciences

  We can build a Diakine™ for every patient.